Page 31 - Read Online
P. 31

Li et al. J Transl Genet Genom 2021;5:163-72               Journal of Translational
               DOI: 10.20517/jtgg.2021.22
                                                                          Genetics and Genomics




               Original Article                                                              Open Access



               Kava root extracts hinder prostate cancer
               development and tumorigenesis by involvement of

               dual inhibition of MAO-A and LSD1

                                                            1
                                              1
                                                                         1
                                     1
                                                                                 1
                                                                                              1,2
                        1
               Xuesen Li , Liankun Song , Shan Xu , Matthew Tippin , Shuan Meng , Jun Xie , Edward Uchio , Xiaolin
               Zi 1,2,3
               1
                Department of Urology, University of California, Irvine, Orang, CA 92868, USA.
               2
                Chao Family Comprehensive Cancer Center, University of California, Orange, CA 92868, USA.
               3
                Department of Pharmaceutical Sciences, University of California, Irvine, Irvine, CA 92617, USA.
               Correspondence to: Prof. Xiaolin Zi, Department of Urology, University of California, Irvine, 101 The City Drive South, Rt.81
               Bldg.55 Rm.204, Orange, CA 92868, USA. E-mail: xzi@uci.edu
               How to cite this article: Li X, Song L, Xu S, Tippin M, Meng S, Xie J, Uchio E, Zi X. Kava root extracts hinder prostate cancer
               development and tumorigenesis by involvement of dual inhibition of MAO-A and LSD1. J Transl Genet Genom 2021;5:163-72.
               https://dx.doi.org/10.20517/jtgg.2021.22
               Received: 14 Apr 2021  First Decision: 14 May 2021  Revised: 16 May 2021  Accepted: 25 May 2021  First online: 28 May 2021
               Academic Editor: Sanjay Gupta  Copy Editor: Xi-Jun Chen  Production Editor: Xi-Jun Chen

               Abstract
               Aim:  Here,  we  aim  to  evaluate  the  chemopreventive  efficacy  of  kava  root  extracts  (KRE)  in  transgenic
               adenocarcinoma of the mouse prostate (TRAMP) mice and investigate potential molecular targets of kavalactones,
               the main components of kava.

               Methods: TRAMP mice were administrated with KRE formulated food for different periods of time, and then the
               incidences of high-grade prostatic intraepithelial neoplasia (HG-PIN) and adenocarcinomas and tumor burdens
               were compared between vehicle control and KRE food fed groups. In addition, the inhibitory effect of the KRE and
               kavalactones on monoamine oxidase A (MAO-A) and lysine-specific demethylase 1 (LSD1) enzyme activities were
               examined by commercially available inhibitor screening kits. Histone H3 lysine 9 dimethylation was also evaluated
               in prostate cancer cells and tumor tissues using Western blotting analysis.

               Results: Dietary feeding of 0.3% and 0.6% KRE to TRAMP mice from ages of 6 weeks to 12 weeks inhibited HG-
               PIN by 43.5% and 59.7%, respectively, and prostate adenocarcinoma by 53.5% and 66.4%, respectively. In
               addition, 0.6% KRE fed TRAMP mice from ages of 6 weeks to 24 weeks exhibited a significant reduction of
               genitourinary weight (a surrogate of tumor burden) by 54.5% and reduced body weight gain. Furthermore, the KRE





                           © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                           www.jtggjournal.com
   26   27   28   29   30   31   32   33   34   35   36